Yahoo News: Cancer

Merck immunotherapy drug shows promise against lymphoma: study

Sat, 12/06/2014 - 18:06
By Bill Berkrot (Reuters) - Merck & Co Inc's drug that harnesses the immune system to fight cancer showed promise in Hodgkin lymphoma patients whose disease had progressed following prior therapies, according to data from a small, early stage trial being presented at a medical meeting. In the ongoing study of 29 patients, 66 percent had a meaningful response to the drug, Keytruda, after 24 weeks ...

High rate of lymphoma patients respond to Bristol-Myers drug: study

Sat, 12/06/2014 - 18:04
By Bill Berkrot (Reuters) - Eighty-seven percent of Hodgkin lymphoma patients responded to a Bristol-Myers Squibb drug that helps the immune system fight the blood cancer, according to data from a small, early stage trial released on Saturday. The study of Bristol-Myers' immunotherapy drug nivolumab involved 23 patients whose lymphoma had progressed after numerous prior treatments, including ...

JPMorgan CEO Dimon says he is free of cancer

Fri, 12/05/2014 - 16:25
NEW YORK (AP) — JPMorgan CEO Jamie Dimon told the bank's staff Friday that he is clear of cancer.

JPMorgan's Dimon says 'no evidence of cancer'

Fri, 12/05/2014 - 15:49
(Reuters) - JPMorgan Chase & Co Chief Executive Jamie Dimon said medical tests showed "no evidence of cancer in my body," according to an internal memo seen by Reuters. Shares of the biggest U.S. bank by assets rose as much as 2.7 percent to a 14-year high of $63.06 in late morning trading. JPMorgan said in July that Dimon, 58, had been diagnosed with throat cancer, but the ailment was curable ...

How Social Media Helps Young People With Cancer

Thu, 12/04/2014 - 16:06
The summer between her sophomore and junior years of high school, Thea Linscott of East Meadows, New York, says her lifelong dance teacher kept asking if she felt OK. Linscott felt fine, apart from a little fatigue, so she was taken aback by the question. But then a strange bump appeared on her shoulder, which a pediatric dermatologist told her to get biopsied.

Geography may limit access to cancer clinical trials

Wed, 12/03/2014 - 21:29
By Kathryn Doyle (Reuters Health) - Where advanced cancer patients live affects the likelihood that they can enroll in a treatment clinical trial, a new study found. Fewer than 10 percent of U.S. cancer patients participate in clinical trials, the authors note. “Clinical trials are the basis for the vast majority of advances in cancer care, so, the only way to move the field forward is for ...

Puma Biotech sinks on cancer drug filing delay

Tue, 12/02/2014 - 22:19
Puma Biotechnology said Tuesday that it won't file for marketing approval of an experimental breast cancer drug until early 2016, sending its shares plunging in aftermarket trading. The company had said ...

Tanzanian leader declares himself free of cancer after surgery

Sat, 11/29/2014 - 14:32
DAR ES SALAAM (Reuters) - Tanzanian president Jakaya Kikwete declared himself cancer-free on Saturday after undergoing prostate surgery in the United States earlier this month. Kikwete, 64, has led east Africa's second-biggest economy since 2005 but must step down next year at the end of his second and final term in office. "I was diagnosed with stage 2 prostate cancer, which was later down ...

Researchers discover 'pre-cancers' in blood

Wed, 11/26/2014 - 22:04
Many older people silently harbor a blood "pre-cancer" — a gene mutation acquired during their lifetime that could start them on the path to leukemia, lymphoma or other blood disease, scientists have discovered. It opens a new frontier on early detection and possibly someday preventing these cancers, which become more common with age.

Breast cancer recurrence risk down since 1980s

Wed, 11/26/2014 - 21:31
By Andrew M. Seaman (Reuters Health) - Rates of breast cancer recurrence fell by half or more between the 1980s and the early 2000s - likely due to improved treatments and increased screenings, according to a new study from Canada. The analysis of data on Canadian breast cancer patients offers reassurance that breast cancer survival is improving and also provides updated data to researchers ...

Fat to blame for half a million cancers a year, WHO agency says

Tue, 11/25/2014 - 23:03
By Kate Kelland LONDON (Reuters) - Some half a million cases of cancer a year are due to people being overweight or obese, and the problem is particularly acute in North America, the World Health Organization's cancer research agency said on Wednesday. In a study published in the journal The Lancet Oncology, the WHO's International Agency for Research on Cancer (IARC) said high body mass index ...

\'Arrow\' Star Stephen Amell Brings Back \'F--- Cancer\' Charity Campaign

Tue, 11/25/2014 - 16:51
Stephen Amell is aiming to take his charity fundraising into seven-digit territory.

Woman who faked son's cancer faces sentencing

Tue, 11/25/2014 - 16:28
CENTENNIAL, Colo. (AP) — A suburban Denver woman who lied about her son having cancer to collect tens of thousands of dollars in charitable contributions is set to be sentenced Tuesday.

Cancer feared for sidelined Chiefs safety Berry

Tue, 11/25/2014 - 06:13
Kansas City Chiefs safety Eric Berry was placed on the NFL non-football illness list after a mass was discovered on the right side of his chest, sparking cancer fears. Chiefs trainer Rick Burkholder on Monday said Berry began feeling discomfort in his chest late in the Chiefs' loss to Oakland last Thursday and that an MRI exam Friday showed the mass in his chest, meaning the "leading ...

NFL - Cancer fear for Chiefs' Berry

Tue, 11/25/2014 - 04:22
- Kansas City Chiefs safety Eric Berry was placed on the NFL non-football illness list after a mass was discovered on the right side of his chest, sparking cancer fears.

Roche's Genentech defends supply shift for top cancer drugs

Mon, 11/24/2014 - 23:41
By Bill Berkrot (Reuters) - Genentech, U.S. biotech unit of Roche Holding, faces growing pressure over a decision to allow only a handful of distributors to supply three of the world's most widely used cancer drugs, a move that prominent hospitals say will create delays and raise costs. Genentech in October began distributing Avastin, Herceptin and Rituxan to hospitals and clinics through six ...

The Link Between Sex and Prostate Cancer (Op-Ed)

Mon, 11/24/2014 - 21:56
Dr. David Samadi is the chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York City and is a board-certified urologist and oncologist specializing in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer and prostate cancer. Evidence continues to accumulate that suggests sexual activity lowers men's prostate cancer risk. The research also ...

Five Prime in cancer drug deal with Bristol-Myers

Mon, 11/24/2014 - 21:20
Five Prime Therapeutics said Monday that it will study a cancer drug regimen that combines one of its drugs with a therapy developed by Bristol-Myers Squibb. Five Prime said it will get $30 million upfront ...

Amgen ends studies of gastric cancer drug

Mon, 11/24/2014 - 18:28
Biotech drugmaker Amgen said Monday it is ending late-stage trials of its gastric cancer treatment rilotumumab because patients who took the drug were more likely to die. Amgen said more patients died ...

FDA strengthens warning on device linked to cancer

Mon, 11/24/2014 - 17:56
TRENTON, N.J. (AP) — U.S. regulators on Monday strengthened their warning against use of a once-popular device for gynecologic surgery that can spread unsuspected cancer, saying its risk is only justified in a fraction of patients.